Advanced breast cancer medicine now available in Slovenia
Ljubljana, 8 June - Alpelizib, the first and only targeted therapy for advanced breast cancer is now accessible to patients in Slovenia, making it one of the few countries where this drug is available. The Institute of Oncology already started treating patients in the compassionate use programme before the drug was registered.
The rest of this news item is available to subscribers.
The news item consists of 1.117 characters (without spaces) or 200 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.